Contact Number: (+639) 8845 0655 | (+63)917 566 4137
Contact Number: (+639) 8845 0655 | (+63)917 566 4137
The Credentialing Program of SGD ensures that our skills and talents remain at par with the world’s best. It also ensures that teammates continue to display the brand of quality and competence for which SGD is known.
In the said program, medical technologists are encouraged to train in any of the specialist streams of Hematology, Immunochemistry and Microbiology. The 30-day intensive program is followed by a series of written and oral examinations. As of writing, SGD has provided specialist training to at least 200 individuals. Truly a remarkable feat considering that SGD has over 300 medical technologists scattered around the more than 40 sites all over the Philippines.
Singapore Diagnostics hosts scientific meetings for the team-members across the country. These scientific meetings are vital in pushing the boundaries of knowledge, fostering collaboration, and driving innovation in the organization.
These scientific gatherings remain as one of SGD's cornerstone in building forward thinkers. This continuously propels the team to be updated with best practices and latest innovations in the scientific community.
The "SGD Future Leaders Program" is a forward-facing initiative of the company designed to identify, nurture, and empower emerging leaders who will play pivotal roles in shaping the company’s future. This is a 3-month program that aims to develop a pool of talented individuals who can address complex challenges, drive innovation, and lead several business units of the organization.
SGD Future Leaders Program is an investment in the future, preparing individuals to take on leadership roles and make meaningful contributions not only in Singapore Diagnostics but also to their communities, organizations, and the country.
The Credentialing Program of SGD ensures that our skills and talents remain at par with the world’s best. It also ensures that teammates continue to display the brand of quality and competence for which SGD is known. In the said program, medical technologists are encouraged to train in any of the specialist streams of Hematology, Immunochemistry and Microbiology. The 30-day intensive program is followed by a series of written and oral examinations. As of writing, SGD has provided specialist training to at least 200 individuals. Truly a remarkable feat considering that SGD has over 300 medical technologists scattered around the more than 40 sites all over the Philippines.
"Lorem Ipsum is simply dummy text of the printing and typesetting industry. "Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged."
"Lorem Ipsum is simply dummy text of the printing and typesetting industry. "Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged."
"Lorem Ipsum is simply dummy text of the printing and typesetting industry. "Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged."
He is currently the Group Managing Director and CEO of Pathology Asia Holdings (Singapore), the largest network of laboratories in Southeast Asia. He is the founder and first CEO of Quantum Diagnostics (Malaysia). He is also a co-founder of Biomark (Singapore). He was the CEO of Innovative Diagnostics (Singapore and HK). He has served as CEO of Timberland Medical Center (Malaysia).
While previously with Healthscope Ltd. (Australia), he oversaw Gribbles Pathology (Malaysia) and Quest Laboratories (Singapore). He was previously with the Economic Development Board of Singapore, specifically the Biomedical Sciences Group. He has participated in the Malaysian government’s healthcare NKEA initiative.
He obtained his medical degree from the University of Melbourne (Australia) and completed his MBA at the Melbourne Business School (Australia).
He is currently the Group Managing Director and CEO of Pathology Asia Holdings (Singapore), the largest network of laboratories in Southeast Asia. He is the founder and first CEO of Quantum Diagnostics (Malaysia). He is also a co-founder of Biomark (Singapore). He was the CEO of Innovative Diagnostics (Singapore and HK). He has served as CEO of Timberland Medical Center (Malaysia).
While previously with Healthscope Ltd. (Australia), he oversaw Gribbles Pathology (Malaysia) and Quest Laboratories (Singapore). He was previously with the Economic Development Board of Singapore, specifically the Biomedical Sciences Group. He has participated in the Malaysian government’s healthcare NKEA initiative.
He obtained his medical degree from the University of Melbourne (Australia) and completed his MBA at the Melbourne Business School (Australia).
While currently the Chief Pathologist of Singapore Diagnostics, Dr. Mendoza is also affiliated with the top hospitals in the Philippines, namely, National Kidney and Transplant Institute, the Cardinal Santos Medical Center, Makati Medical Center and the Asian Hospital Medical Center.
He received his medical degree from UST and had residency training at NKTI. He is board-certified in Anatomic and Clinical Pathology by PSP. Furthermore, he pursued training in Breast and Liver Pathology at Singapore General Hospital (SGH), Prince of Wales Hospital (HK) and Beth Israel Medical Center (USA)
A results-driven healthcare professional with over 30 years of extensive experience in laboratory operations, business development, commercial strategy, and people management. Her career has been marked by a proven track record of driving operational excellence, fostering strong relationships, and spearheading growth and innovation initiatives within various organizations. Ms. Gil's contributions to the company had a vital role in Singapore Diagnostics' efforts to survive and aid the Filipino people during the height of the covid-19 pandemic.
Her decades of laboratory experience started from National Kidney Transplant Institute and she received her post graduate certification from National University of Singapore.